Moore CB - Search Results

1

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.

Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Felton TW, et al. Among authors: moore cb. Clin Infect Dis. 2010 Dec 15;51(12):1383-91. doi: 10.1086/657306. Epub 2010 Nov 5. Clin Infect Dis. 2010. PMID: 21054179

2

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MG, Denning DW. Law D, et al. Among authors: moore cb. J Antimicrob Chemother. 1994 Nov;34(5):659-68. doi: 10.1093/jac/34.5.659. J Antimicrob Chemother. 1994. PMID: 7706161

3

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.

Wardle HM, Law D, Moore CB, Mason C, Denning DW. Wardle HM, et al. Among authors: moore cb. Antimicrob Agents Chemother. 1995 Apr;39(4):868-71. doi: 10.1128/AAC.39.4.868. Antimicrob Agents Chemother. 1995. PMID: 7785986 Free PMC article.

4

Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards.

Law D, Moore CB, Denning DW. Law D, et al. Among authors: moore cb. Antimicrob Agents Chemother. 1994 Jul;38(7):1561-6. doi: 10.1128/AAC.38.7.1561. Antimicrob Agents Chemother. 1994. PMID: 7979289 Free PMC article.

5

In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.

Moore CB, Law D, Denning DW. Moore CB, et al. J Antimicrob Chemother. 1993 Dec;32(6):831-6. doi: 10.1093/jac/32.6.831. J Antimicrob Chemother. 1993. PMID: 8144422

6

Isolation of Candida norvegensis from clinical specimens: four case reports.

Hood SV, Moore CB, Denning DW. Hood SV, et al. Among authors: moore cb. Clin Infect Dis. 1996 Nov;23(5):1185-7. doi: 10.1093/clinids/23.5.1185. Clin Infect Dis. 1996. PMID: 8922831 No abstract available.

7

In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.

Oakley KL, Moore CB, Denning DW. Oakley KL, et al. Among authors: moore cb. Antimicrob Agents Chemother. 1997 May;41(5):1124-6. doi: 10.1128/AAC.41.5.1124. Antimicrob Agents Chemother. 1997. PMID: 9145880 Free PMC article.

8

Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains.

Nho S, Anderson MJ, Moore CB, Denning DW. Nho S, et al. Among authors: moore cb. J Clin Microbiol. 1997 Apr;35(4):1036-9. doi: 10.1128/jcm.35.4.1036-1039.1997. J Clin Microbiol. 1997. PMID: 9157129 Free PMC article.

9

Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.

Hood SV, Moore CB, Cheesbrough JS, Mene A, Denning DW. Hood SV, et al. Among authors: moore cb. Br J Dermatol. 1997 Jun;136(6):953-6. Br J Dermatol. 1997. PMID: 9217835

10

Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.

Baily GG, Moore CB, Essayag SM, de Wit S, Burnie JP, Denning DW. Baily GG, et al. Among authors: moore cb. Clin Infect Dis. 1997 Jul;25(1):161-3. doi: 10.1086/516894. Clin Infect Dis. 1997. PMID: 9243058 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters